Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1981 1
1985 1
1991 1
1993 1
1994 2
1995 1
1996 1
1997 3
1998 3
1999 1
2000 1
2002 2
2003 4
2005 2
2006 1
2007 3
2008 3
2009 3
2010 7
2011 5
2012 5
2013 7
2014 9
2015 11
2016 6
2017 9
2018 6
2019 3
2020 5
2021 6
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features and presentation of oral potentially malignant disorders.
Warnakulasuriya S. Warnakulasuriya S. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):582-590. doi: 10.1016/j.oooo.2018.03.011. Epub 2018 Apr 4. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 29673799 Free article. Review.
Leukoplakia is the most common OPMD; erythroplakia, although rare, is more serious. Several variants of leukoplakia are recognized, and clinical subtyping may help determine the prognosis to a limited extent. Biopsy is essential to confirm the provisional clinical d …
Leukoplakia is the most common OPMD; erythroplakia, although rare, is more serious. Several variants of leukoplakia are recognized, and c …
Dyskeratosis Congenita.
Stoopler ET, Shanti RM. Stoopler ET, et al. Mayo Clin Proc. 2019 Sep;94(9):1668-1669. doi: 10.1016/j.mayocp.2019.04.032. Mayo Clin Proc. 2019. PMID: 31486376 Review. No abstract available.
Dyskeratosis congenita.
Gupta V, Kumar A. Gupta V, et al. Adv Exp Med Biol. 2010;685:215-9. doi: 10.1007/978-1-4419-6448-9_20. Adv Exp Med Biol. 2010. PMID: 20687509 Free article. Review.
Dyskeratosis congenita (DC) is an inheritable bone marrow failure syndrome characterized by reticulated hyperpigmentation, dystrophic nails and oral leukoplakia. ...
Dyskeratosis congenita (DC) is an inheritable bone marrow failure syndrome characterized by reticulated hyperpigmentation, dys …
Reticulate hyperpigmentation.
Schnur RE, Heymann WR. Schnur RE, et al. Semin Cutan Med Surg. 1997 Mar;16(1):72-80. doi: 10.1016/s1085-5629(97)80038-7. Semin Cutan Med Surg. 1997. PMID: 9125768 Review.
Disorders that are characterized by a reticulate pattern of pigmentation are reviewed. Dyskeratosis congenita (DKC) is the prototype of these. In addition to reticulate hyperpigmentation, mucosal leukoplakia, bone marrow dysfunction, cytogenetic instability, and a p …
Disorders that are characterized by a reticulate pattern of pigmentation are reviewed. Dyskeratosis congenita (DKC) is the pro …
Allogeneic hematopoietic stem cell transplantation for dyskeratosis congenita.
Elmahadi S, Muramatsu H, Kojima S. Elmahadi S, et al. Curr Opin Hematol. 2016 Nov;23(6):501-507. doi: 10.1097/MOH.0000000000000290. Curr Opin Hematol. 2016. PMID: 27607446 Review.
PURPOSE OF REVIEW: Dyskeratosis congenita is an inherited bone marrow failure syndrome caused by defects in telomere maintenance. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for bone marrow failure because of dyskeratosis …
PURPOSE OF REVIEW: Dyskeratosis congenita is an inherited bone marrow failure syndrome caused by defects in telomere maintenan …
Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV, Bessler M. Babushok DV, et al. Best Pract Res Clin Haematol. 2015 Mar;28(1):55-68. doi: 10.1016/j.beha.2014.11.004. Epub 2014 Nov 12. Best Pract Res Clin Haematol. 2015. PMID: 25659730 Free PMC article. Review.
In addition to the classic hereditary bone marrow failure syndromes (BMFS) such as Fanconi Anemia and Dyskeratosis Congenita, in recent years there has been an increased awareness of non-syndromic familial MDS/AML predisposition syndromes such as those caused by mut …
In addition to the classic hereditary bone marrow failure syndromes (BMFS) such as Fanconi Anemia and Dyskeratosis Congenita, …
Treatment of inherited bone marrow failure syndromes beyond transplantation.
Calado RT, Clé DV. Calado RT, et al. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):96-101. doi: 10.1182/asheducation-2017.1.96. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222242 Free PMC article. Review.
Androgens are the main nontransplant therapy for bone marrow failure in dyskeratosis congenita and Fanconi anemia, reaching responses in up to 80% of cases. ...
Androgens are the main nontransplant therapy for bone marrow failure in dyskeratosis congenita and Fanconi anemia, reaching re …
Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita.
Thompson MB, Muldoon D, de Andrade KC, Giri N, Alter BP, Savage SA, Shamburek RD, Khincha PP. Thompson MB, et al. EBioMedicine. 2022 Jan;75:103760. doi: 10.1016/j.ebiom.2021.103760. Epub 2021 Dec 17. EBioMedicine. 2022. PMID: 34929494 Free PMC article.
BACKGROUND: Dyskeratosis congenita (DC) is a telomere biology disorder associated with high rates of bone marrow failure (BMF) and other medical complications. ...INTERPRETATION: Androgen treatment in DC creates an atherogenic lipoprotein profile, raising concern fo …
BACKGROUND: Dyskeratosis congenita (DC) is a telomere biology disorder associated with high rates of bone marrow failure (BMF) …
Inherited aplastic anaemia.
Dokal I. Dokal I. Hematol J. 2003;4(1):3-9. doi: 10.1038/sj.thj.6200215. Hematol J. 2003. PMID: 12692514 Review.
In recent years, there have been significant advances in the genetics of Fanconi anaemia (FA), dyskeratosis congenita (DC) and other BM failure syndromes. This is facilitating accurate diagnosis and beginning to unravel their pathophysiology. ...
In recent years, there have been significant advances in the genetics of Fanconi anaemia (FA), dyskeratosis congenita (DC) and …
Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes?
Hudda Z, Myers KC. Hudda Z, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):141-148. doi: 10.1182/hematology.2023000471. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066882
The most common IBMFS include Fanconi anemia, Shwachman-Diamond syndrome, Diamond-Blackfan anemia, and telomere biology disorders/ dyskeratosis congenita. Allogeneic hematopoietic stem cell transplant (HCT) is a well-established curative treatment to correct the hem …
The most common IBMFS include Fanconi anemia, Shwachman-Diamond syndrome, Diamond-Blackfan anemia, and telomere biology disorders/ dysker …
106 results